Chen‐Hua Liu
About
Chen‐Hua Liu is a scholar working on Hepatology, Epidemiology and Infectious Diseases.
According to data from OpenAlex, Chen‐Hua Liu has authored 194 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 151 papers in Hepatology, 142 papers in Epidemiology and 12 papers in Infectious Diseases. Recurrent topics in Chen‐Hua Liu's work include Hepatitis C virus research (133 papers), Liver Disease Diagnosis and Treatment (125 papers) and Hepatitis B Virus Studies (109 papers). Chen‐Hua Liu is often cited by papers focused on Hepatitis C virus research (133 papers), Liver Disease Diagnosis and Treatment (125 papers) and Hepatitis B Virus Studies (109 papers). Chen‐Hua Liu collaborates with scholars based in Taiwan, United States and China. Chen‐Hua Liu's co-authors include Jia‐Horng Kao, Pei‐Jer Chen, Chun‐Jen Liu, Ding‐Shinn Chen, Tai‐Chung Tseng, Tung‐Hung Su, Hung‐Chih Yang, Chi‐Ling Chen, Stephanie Fang–Tzu Kuo and Ching‐Sheng Hsu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Annals of Internal Medicine.
In The Last Decade
Chen‐Hua Liu
189 papers receiving 4.7k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Chen‐Hua Liu Taiwan | 38 | 3.8k | 3.8k | 316 | 246 | 185 | 194 | 4.8k | ||
| Johannes Vermehren Germany | 31 | 2.7k 0.7× | 2.7k 0.7× | 493 1.6× | 168 0.7× | 203 1.1× | 111 | 3.5k | ||
| Dar‐In Tai Taiwan | 28 | 3.9k 1.0× | 4.1k 1.1× | 655 2.1× | 470 1.9× | 614 3.3× | 99 | 5.6k | ||
| Javier Bartolomé Spain | 32 | 2.5k 0.7× | 2.4k 0.6× | 307 1.0× | 155 0.6× | 77 0.4× | 148 | 3.3k | ||
| Pieter E. Zondervan Netherlands | 36 | 2.6k 0.7× | 2.8k 0.7× | 266 0.8× | 326 1.3× | 1.2k 6.5× | 142 | 4.7k | ||
| Jerzy Jaroszewicz Poland | 28 | 1.5k 0.4× | 1.5k 0.4× | 678 2.1× | 253 1.0× | 178 1.0× | 163 | 2.9k | ||
| Hideyuki Nomura Japan | 27 | 1.5k 0.4× | 1.6k 0.4× | 250 0.8× | 109 0.4× | 193 1.0× | 177 | 3.1k | ||
| Meng Yin United States | 40 | 3.6k 1.0× | 5.1k 1.4× | 256 0.8× | 432 1.8× | 883 4.8× | 152 | 7.2k | ||
| Makoto Arai Japan | 24 | 1.3k 0.3× | 1.2k 0.3× | 128 0.4× | 313 1.3× | 439 2.4× | 185 | 2.5k | ||
| Clara Milikowski United States | 15 | 1.4k 0.4× | 1.7k 0.5× | 109 0.3× | 260 1.1× | 242 1.3× | 51 | 2.6k | ||
| Chang Wook Kim South Korea | 24 | 1.3k 0.3× | 1.1k 0.3× | 100 0.3× | 205 0.8× | 319 1.7× | 99 | 2.0k |
Countries citing papers authored by Chen‐Hua Liu
Since
Specialization
Citations
This map shows the geographic impact of Chen‐Hua Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chen‐Hua Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chen‐Hua Liu more than expected).
Fields of papers citing papers by Chen‐Hua Liu
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Chen‐Hua Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chen‐Hua Liu. The network helps show where Chen‐Hua Liu may publish in the future.
Co-authorship network of co-authors of Chen‐Hua Liu
This figure shows the co-authorship network connecting the top 25 collaborators of Chen‐Hua Liu. A scholar is included among the top collaborators of Chen‐Hua Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chen‐Hua Liu. Chen‐Hua Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Tseng, Tai‐Chung, Yao‐Chun Hsu, Tung‐Hung Su, et al.. (2025). Expert consensus on clinical usefulness of M2BPGi for managing chronic liver diseases. Journal of the Formosan Medical Association. 124(11). 1010–1017.
2.
Chang, Yu‐Ping, Jia‐Horng Kao, Tung‐Hung Su, et al.. (2025). Long-term serum ferritin dynamics in patients receiving antiviral treatment for hepatitis C virus infection. Journal of the Formosan Medical Association. 125(3). 283–290.
3.
Tseng, Tai‐Chung, Tetsuya Hosaka, Chun‐Jen Liu, et al.. (2025). Higher level of HBsAg associated with delayed development of HCC in immune-tolerant patients. Hepatology. 83(1). 142–155.
4.
Tseng, Tai‐Chung, Shang‐Chin Huang, Chun‐Jen Liu, et al.. (2025). Hepatitis B surface antigen level identifies patients with inactive chronic hepatitis B from Asia with HCC risk below surveillance threshold. Gut. 74(11). 1896–1904.
5.
Chang, Kai‐Chun, Tung‐Hung Su, Cho‐Kai Wu, et al.. (2025). Metabolic Dysfunction-Associated Steatotic Liver Disease is Associated with Increased Risks of Heart Failure. European Journal of Heart Failure. 27(3). 512–520.
6.
Chang, Yu‐Ping, Ji‐Yuh Lee, Chi‐Yi Chen, et al.. (2025). Predictive Value of Serum Mac‐2 Binding Protein Glycosylation Isomer for Hepatic Fibrosis in Hepatitis C Virus–Infected Patients With Metabolic Dysfunction–Associated Steatotic Liver Disease. Journal of Gastroenterology and Hepatology. 41(1). 322–331.
7.
Tseng, Tai‐Chung, Chun‐Jen Liu, Chun‐Ming Hong, et al.. (2023). Low Hepatitis B Core–Related Antigen Levels Correlate Higher Spontaneous Seroclearance of Hepatitis B Surface Antigen in Chronic Hepatitis B Patients With High Hepatitis B Surface Antigen Levels. Gastroenterology. 164(4). 669–679.e6.
8.
Tseng, Tai‐Chung, Tetsuya Hosaka, Chun‐Jen Liu, et al.. (2023). HBcrAg-based risk score performs better than the HBV DNA-based scores for HCC prediction in grey zone patients who are HBeAg-negative. JHEP Reports. 6(1). 100956–100956.
9.
Liu, Chen‐Hua, Hsin‐Yun Sun, Cheng‐Yuan Peng, et al.. (2022). Hepatitis C Virus Reinfection in People With HIV in Taiwan After Achieving Sustained Virologic Response With Antiviral Treatment: The RECUR Study. Open Forum Infectious Diseases. 9(8). ofac348–ofac348.
10.
Liu, Chen‐Hua, Hsin‐Yun Sun, Szu‐Min Hsieh, et al.. (2021). Evolution of estimated glomerular filtration rate in human immunodeficiency virus and hepatitis C virus‐coinfected patients receiving sofosbuvir‐based direct‐acting antivirals and antiretroviral therapy. Journal of Viral Hepatitis. 28(6). 887–896.
11.
Tseng, Tai‐Chung, Chun‐Jen Liu, Wanting Yang, et al.. (2021). Serum hepatitis B core‐related antigen level stratifies risk of disease progression in chronic hepatitis B patients with intermediate viral load. Alimentary Pharmacology & Therapeutics. 53(8). 908–918.
12.
Yang, Wanting, Liwei Wu, Tai‐Chung Tseng, et al.. (2016). Hepatitis B Surface Antigen Loss and Hepatocellular Carcinoma Development in Patients With Dual Hepatitis B and C Infection. Medicine. 95(10). e2995–e2995.
13.
Liu, Chen‐Hua & Jia‐Horng Kao. (2016). Hepatocellular carcinoma recurrence after interferon-free direct acting antiviral treatment for chronic hepatitis C virus infection: fact or fiction?. Translational Cancer Research. 5(2).
14.
Liu, Chen‐Hua, Cheng‐Chao Liang, Chun‐Jen Liu, et al.. (2015). Comparison of Abbott RealTime HCV Genotype II with Versant Line Probe Assay 2.0 for Hepatitis C Virus Genotyping. Journal of Clinical Microbiology. 53(5). 1754–1757.
15.
Tseng, Tai‐Chung, Chun‐Jen Liu, Hung‐Chih Yang, et al.. (2014). Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriers. Gut. 64(2). 292–302.
16.
Chen, Ming‐Yao, Chen‐Hua Liu, Tung‐Hung Su, et al.. (2013). Value of interleukin‐28B genetic polymorphism on retreatment outcomes of chronic hepatitis C genotype 1 relapsers by peginterferon alfa plus ribavirin. Journal of Gastroenterology and Hepatology. 29(1). 102–109.
17.
Yu, Ming‐Lung, Chuan–Mo Lee, Chi‐Ling Chen, et al.. (2013). Sustained hepatitis C virus clearance and increased hepatitis B surface antigen seroclearance in patients with dual chronic hepatitis C and B during posttreatment follow-up. Hepatology. 57(6). 2135–2142.
18.
Liu, Chen‐Hua, et al.. (2012). Effect of Oral Administration of Pheretima Aspergillum (Earthworm) in Rats with Cerebral Infarction Induced by Middle-Cerebral Artery Occlusion. African Journal of Traditional Complementary and Alternative Medicines. 10(1). 66–82.
19.
Tseng, Tai‐Chung, Chun‐Jen Liu, Tung‐Hung Su, et al.. (2012). Young Chronic Hepatitis B Patients With Nucleos(t)ide Analogue-induced Hepatitis B e Antigen Seroconversion Have a Higher Risk of HBV Reactivation. The Journal of Infectious Diseases. 206(10). 1521–1531.
20.
Liu, Chun‐Jen, Yung‐Ming Jeng, Pei‐Jer Chen, et al.. (2009). Hepatitis B Virus Basal Core Promoter Mutation and DNA Load Correlate with Expression of Hepatitis B Core Antigen in Patients with Chronic Hepatitis B. The Journal of Infectious Diseases. 199(5). 742–749.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Johannes Vermehren Breakdown of academic impact, for papers by Dar‐In Tai Breakdown of academic impact, for papers by Javier Bartolomé Breakdown of academic impact, for papers by Pieter E. Zondervan Breakdown of academic impact, for papers by Jerzy Jaroszewicz Breakdown of academic impact, for papers by Hideyuki Nomura Breakdown of academic impact, for papers by Meng Yin Breakdown of academic impact, for papers by Makoto Arai Breakdown of academic impact, for papers by Clara Milikowski Breakdown of academic impact, for papers by Chang Wook Kim